Level of Plasma Tissue Factor Pathway Inhibitor is Inversely Correlated With Intraarterial Diastolic Pressure in Subjects Who Underwent Coronary Angiography
There are only a few studies of the relationship between hemostatic abnormalities and intraarterial pressure, so the present study investigated the association of various newer lipid and hemostatic variables with intraarterial pressure levels. Levels of total cholesterol, high-density lipoprotein ch...
Saved in:
| Published in | JAPANESE CIRCULATION JOURNAL Vol. 65; no. 3; pp. 165 - 170 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Kyoto
The Japanese Circulation Society
2001
Japanese Circulation Society |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0047-1828 1347-4839 1347-4839 |
| DOI | 10.1253/jcj.65.165 |
Cover
| Abstract | There are only a few studies of the relationship between hemostatic abnormalities and intraarterial pressure, so the present study investigated the association of various newer lipid and hemostatic variables with intraarterial pressure levels. Levels of total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol, triglyceride, lipoprotein-(a), remnant-like particle cholesterol, cholesteryl ester transfer protein, uric acid, blood glucose, fibrinogen, free form of tissue factor pathway inhibitor (TFPI), C-reactive protein, serum amyloid A protein, anti-Chlamydia pneumoniae immunoglobulin G and immunoglobulin A, and apolipoproteins (apo) A-I, B, and E were measured in 176 patients who underwent diagnostic coronary angiography. Intraarterial blood pressure was determined from central aortic pressure using a standard fluid-filled catheter-external transducer system. Multivariate regression analyses showed that TFPI level was the only independent factor associated with aortic diastolic pressure. The linear regression equation demonstrated a significant negative correlation of TFPI level with aortic diastolic pressure (r=−0.395, p=0.0011). With respect to the association with other parameters, the TFPI level showed significant correlations between the HDL-C level and the apo A-I level, both in the overall patients and in the patients with coronary artery stenosis. This is the first evidence that the level of the plasma free form of TFPI is inversely correlated to aortic diastolic pressure. (Jpn Circ J 2001; 65: 165 - 170) |
|---|---|
| AbstractList | There are only a few studies of the relationship between hemostatic abnormalities and intraarterial pressure, so the present study investigated the association of various newer lipid and hemostatic variables with intraarterial pressure levels. Levels of total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol, triglyceride, lipoprotein-(a), remnant-like particle cholesterol, cholesteryl ester transfer protein, uric acid, blood glucose, fibrinogen, free form of tissue factor pathway inhibitor (TFPI), C-reactive protein, serum amyloid A protein, anti-Chlamydia pneumoniae immunoglobulin G and immunoglobulin A, and apolipoproteins (apo) A-I, B, and E were measured in 176 patients who underwent diagnostic coronary angiography. Intraarterial blood pressure was determined from central aortic pressure using a standard fluid-filled catheter-external transducer system. Multivariate regression analyses showed that TFPI level was the only independent factor associated with aortic diastolic pressure. The linear regression equation demonstrated a significant negative correlation of TFPI level with aortic diastolic pressure (r=−0.395, p=0.0011). With respect to the association with other parameters, the TFPI level showed significant correlations between the HDL-C level and the apo A-I level, both in the overall patients and in the patients with coronary artery stenosis. This is the first evidence that the level of the plasma free form of TFPI is inversely correlated to aortic diastolic pressure. (Jpn Circ J 2001; 65: 165 - 170) There are only a few studies of the relationship between hemostatic abnormalities and intraarterial pressure, so the present study investigated the association of various newer lipid and hemostatic variables with intraarterial pressure levels. Levels of total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol, triglyceride, lipoprotein-(a), remnant-like particle cholesterol, cholesteryl ester transfer protein, uric acid, blood glucose, fibrinogen, free form of tissue factor pathway inhibitor (TFPI), C-reactive protein, serum amyloid A protein, anti-Chlamydia pneumoniae immunoglobulin G and immunoglobulin A, and apolipoproteins (apo) A-I, B, and E were measured in 176 patients who underwent diagnostic coronary angiography. Intraarterial blood pressure was determined from central aortic pressure using a standard fluid-filled catheter-external transducer system. Multivariate regression analyses showed that TFPI level was the only independent factor associated with aortic diastolic pressure. The linear regression equation demonstrated a significant negative correlation of TFPI level with aortic diastolic pressure (r=-0.395, p=0.0011). With respect to the association with other parameters, the TFPI level showed significant correlations between the HDL-C level and the apo A-I level, both in the overall patients and in the patients with coronary artery stenosis. This is the first evidence that the level of the plasma free form of TFPI is inversely correlated to aortic diastolic pressure.There are only a few studies of the relationship between hemostatic abnormalities and intraarterial pressure, so the present study investigated the association of various newer lipid and hemostatic variables with intraarterial pressure levels. Levels of total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol, triglyceride, lipoprotein-(a), remnant-like particle cholesterol, cholesteryl ester transfer protein, uric acid, blood glucose, fibrinogen, free form of tissue factor pathway inhibitor (TFPI), C-reactive protein, serum amyloid A protein, anti-Chlamydia pneumoniae immunoglobulin G and immunoglobulin A, and apolipoproteins (apo) A-I, B, and E were measured in 176 patients who underwent diagnostic coronary angiography. Intraarterial blood pressure was determined from central aortic pressure using a standard fluid-filled catheter-external transducer system. Multivariate regression analyses showed that TFPI level was the only independent factor associated with aortic diastolic pressure. The linear regression equation demonstrated a significant negative correlation of TFPI level with aortic diastolic pressure (r=-0.395, p=0.0011). With respect to the association with other parameters, the TFPI level showed significant correlations between the HDL-C level and the apo A-I level, both in the overall patients and in the patients with coronary artery stenosis. This is the first evidence that the level of the plasma free form of TFPI is inversely correlated to aortic diastolic pressure. There are only a few studies of the relationship between hemostatic abnormalities and intraarterial pressure, so the present study investigated the association of various newer lipid and hemostatic variables with intraarterial pressure levels. Levels of total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol, triglyceride, lipoprotein-(a), remnant-like particle cholesterol, cholesteryl ester transfer protein, uric acid, blood glucose, fibrinogen, free form of tissue factor pathway inhibitor (TFPI), C-reactive protein, serum amyloid A protein, anti-Chlamydia pneumoniae immunoglobulin G and immunoglobulin A, and apolipoproteins (apo) A-I, B, and E were measured in 176 patients who underwent diagnostic coronary angiography. Intraarterial blood pressure was determined from central aortic pressure using a standard fluid-filled catheter-external transducer system. Multivariate regression analyses showed that TFPI level was the only independent factor associated with aortic diastolic pressure. The linear regression equation demonstrated a significant negative correlation of TFPI level with aortic diastolic pressure (r=-0.395, p=0.0011). With respect to the association with other parameters, the TFPI level showed significant correlations between the HDL-C level and the apo A-I level, both in the overall patients and in the patients with coronary artery stenosis. This is the first evidence that the level of the plasma free form of TFPI is inversely correlated to aortic diastolic pressure. |
| Author | Ozaki, Morihiro Kawasaki, Atsushi Masuoka, Hiroshi Ito, Masaaki Kamei, Shigeru Nakano, Takeshi |
| Author_xml | – sequence: 1 fullname: Ito, Masaaki organization: First Department of Internal Medicine, Mie University School of Medicine – sequence: 1 fullname: Nakano, Takeshi organization: First Department of Internal Medicine, Mie University School of Medicine – sequence: 1 fullname: Ozaki, Morihiro organization: Division of Cardiology, National Mie Central Hospital – sequence: 1 fullname: Masuoka, Hiroshi organization: Division of Cardiology, National Mie Central Hospital – sequence: 1 fullname: Kawasaki, Atsushi organization: Division of Cardiology, National Mie Central Hospital – sequence: 1 fullname: Kamei, Shigeru organization: Division of Cardiology, National Mie Central Hospital |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=924510$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/11266189$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kd1qGzEQhUVJaZy0N32AIij0osWutL_aqxLcpg0YamhCLpdZ7axXiyw5kjbG75KHjYxdF0rpjaTRfOcwnLkgZ8YaJOQtZzOe5OnnQQ6zIp_xIn9BJjzNymkm0uqMTBiLby4ScU4uvB8YS8osz1-Rc86TouCimpCnBT6iprajSw1-DfRWeT8ivQYZrKNLCP0WdvTG9KpR-x_lY_GIzqPe0bl1DjUEbOm9Cn3sBAfgAjoFmn5V4IPVStKlw-jqkCpDf43NgDJ4et9bemdadFs0YW9lDbgdvTIrZVcONv3uNXnZgfb45nhfkrvrb7fzH9PFz-8386vFVGZVGqYppKyoKtG0FctRNFkmRMZbIWXVdAKKrmtKwQvJkkx0WdflaQOi4RyRQSLaJr0knw6-o9nAbgta1xun1nGamrN6n3EdM66LvI4ZR_rDgd44-zCiD_VaeYlag0E7-rqMsxSsTCL47giOzRrbP57H9CPw_giAl6A7B0Yqf-KqJMs5i9THAyWd9d5h9__h2F-wVAGCsvvNKP1vyZeDZPABVnhyj3tUUuNvND0cUXHqyB5cjSZ9Bm9EzLM |
| CODEN | JCIRA2 |
| CitedBy_id | crossref_primary_10_1536_ihj_46_69 crossref_primary_10_1177_0003319712469276 |
| Cites_doi | 10.1161/01.CIR.51.4.5 10.1093/clinchem/39.2.293 10.1016/0009-8981(93)90062-9 10.1136/hrt.71.1.41 10.7326/0003-4819-132-3-200002010-00010 10.1161/01.CIR.84.2.821 10.1161/01.ATV.12.10.1111 10.1161/01.CIR.94.6.1226 10.1021/bi00485a001 10.1161/01.ATV.15.4.504 10.1055/s-0038-1646367 10.1161/01.CIR.101.6.611 10.1097/00001721-199106000-00004 10.1093/oxfordjournals.jbchem.a124874 10.1002/jcla.1860050204 10.1161/01.CIR.100.4.354 10.1097/00001721-199203040-00011 10.1038/338518a0 10.1161/01.ATV.14.2.223 10.1161/01.ATV.11.1.138 10.1097/00004872-199301000-00001 10.1073/pnas.86.8.2839 10.1182/blood.V71.1.1.1 10.1161/01.RES.50.5.747 10.1016/S0049-3848(99)00112-7 10.1161/01.ATV.16.6.802 10.1097/00001721-199112000-00004 |
| ContentType | Journal Article |
| Copyright | 2001 THE JAPANESE CIRCULATION SOCIETY 2001 INIST-CNRS |
| Copyright_xml | – notice: 2001 THE JAPANESE CIRCULATION SOCIETY – notice: 2001 INIST-CNRS |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 ADTOC UNPAY |
| DOI | 10.1253/jcj.65.165 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1347-4839 |
| EndPage | 170 |
| ExternalDocumentID | 10.1253/jcj.65.165 11266189 924510 10_1253_jcj_65_165 article_jcj_65_3_65_3_165_article_char_en |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | .55 .GJ 29J 2WC 3O- 53G 5GY 5RE ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK E3Z F5P JSF JSH KQ8 OK1 RJT RNS RZJ TKC TR2 W2D X7J X7M ZGI ZXP AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 ADTOC UNPAY |
| ID | FETCH-LOGICAL-c493t-3a306998bd905e8b448841d8cc9bf8a6ffb7816c0248f4ff53ba8b11ee0a28db3 |
| IEDL.DBID | UNPAY |
| ISSN | 0047-1828 1347-4839 |
| IngestDate | Thu Aug 28 11:18:50 EDT 2025 Fri Jul 11 10:42:25 EDT 2025 Thu May 23 23:48:12 EDT 2024 Wed Apr 02 07:43:25 EDT 2025 Tue Jul 01 03:13:33 EDT 2025 Thu Apr 24 23:00:30 EDT 2025 Wed Sep 03 06:13:38 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Issue | 3 |
| Keywords | Human Diastolic pressure Prognosis Radiodiagnosis Angiography Coronary artery Tissue factor Cardiovascular disease Inhibitor Coronary heart disease Artery Blood plasma |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c493t-3a306998bd905e8b448841d8cc9bf8a6ffb7816c0248f4ff53ba8b11ee0a28db3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://www.jstage.jst.go.jp/article/jcj/65/3/65_3_165/_pdf |
| PMID | 11266189 |
| PQID | 76996072 |
| PQPubID | 23479 |
| PageCount | 6 |
| ParticipantIDs | unpaywall_primary_10_1253_jcj_65_165 proquest_miscellaneous_76996072 pubmed_primary_11266189 pascalfrancis_primary_924510 crossref_primary_10_1253_jcj_65_165 crossref_citationtrail_10_1253_jcj_65_165 jstage_primary_article_jcj_65_3_65_3_165_article_char_en |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2001-00-00 |
| PublicationDateYYYYMMDD | 2001-01-01 |
| PublicationDate_xml | – year: 2001 text: 2001-00-00 |
| PublicationDecade | 2000 |
| PublicationPlace | Kyoto |
| PublicationPlace_xml | – name: Kyoto – name: Japan |
| PublicationTitle | JAPANESE CIRCULATION JOURNAL |
| PublicationTitleAlternate | JAPANESE CIRCULATION JOURNAL |
| PublicationYear | 2001 |
| Publisher | The Japanese Circulation Society Japanese Circulation Society |
| Publisher_xml | – name: The Japanese Circulation Society – name: Japanese Circulation Society |
| References | 22. Smulyan H, Safar ME: The diastolic blood pressure in systolic hypertension. Ann Intern Med 2000; 132: 233-237 19. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D: Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999; 100: 354-360 23. Zweifler AJ, Shahab ST: Pseudohypertension: A new assessment. J Hypertens 1993; 11: 1-6 9. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LSC, et al: A reporting system on patients evaluated for coronary artery disease: Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51: 5-40 26. Hansen JB, Huseby NE, Sandset PM, Svensson B, Lyngmo V, Nordoy A: Tissue factor pathway inhibitor and lipoproteins: Evidence for association with and regulation by LDL in human plasma. Arterioscler Thromb 1994; 14: 223-229 3. Wilcox JN, Smith KM, Scwartz SM, Gordon D: Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-2843 8. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, et al: Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta 1993; 223: 53-71 16. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, et al: Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 1989; 338: 518-520 25. Sandset PM, Lund H, Norseth J, Abildgaard U, Ose L: Treatment with hydroxymethylglutaryl: Coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system. Arterioscler Thromb 1991; 11: 138-145 6. Lindahl AK, Sandset PM, Abildgaard U: The present status of tissue factor pathway inhibitor. Blood Coagul Fibrinolysis 1992; 3: 439-449 2. Nemerson Y: Tissue factor and haemostasis. Blood 1988; 71: 1-8 18. Bellamy RF: Diastolic coronary artery pressure: Flow relations in the dog. Circ Res 1982; 50: 334-341 4. Broze GJ, Girard TJ, Novotny WF: Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990; 29: 7539-7546 11. Ikeda T, Shibuya Y, Senba U, Sugiuchi H, Araki S, Uji Y, et al: Automated immunoturbidimetric analysis of six plasma apolipoproteins: Correlation with radial immunodiffusion assays. J Clin Lab Anal 1991; 5: 90-95 15. Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, et al: Identification of active tissue factor in human coronary atheroma. Circulation 1996; 94: 1226-1232 24. Kokawa T, Abumiya T, Kimura T, Harada-Shiba M, Koh H, Tsushima M, et al: Tissue factor pathway inhibitor activity in human plasma: Measurement of lipoprotein-associated and free forms in hyperlipidemia. Arterioscler Thromb Vasc Biol 1995; 15: 504-510 31. Swan JW, Walton C, Godsland IF, Crook D, Oliver MF, Stevenson JC: Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men. Br Heart J 1994; 71: 41-44 5. Rappaport SI: The extrinsic pathway inhibitor: A regulator of TF-dependent blood coagulation. Thromb Haemost 1991; 66: 6-10 12. Haskel EJ, Torr SR, Day KC, Palmier MO, Wun T-C, Sobel BE, et al: Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation 1991; 84: 821-827 17. Kokawa T, Enjyoji K, Kumeda K, Kamikubo Y, Harada-Shiba M, Koh H, et al: Measurement of the free form of TFPI antigen in hyperlipidemia: Relationship between free and endothelial cell-associated forms of TFPI. Arterioscler Thromb Vasc Biol 1996; 16: 802-808 7. Abumiya T, Enjyoji K, Kokawa T, Kamikubo Y, Kato H: An anti tissue factor pathway inhibitor (TFPI) monoclonal antibody recognized the third Kunitz domain (K3) of free form of TFPI but not lipoprotein-associated forms in plasma. J Biochem 1995; 118: 178-182 28. Rugeri L, Susen S, Bard JM, Corseaux D, Gaveriaux V, Devos P, et al: Monocyte tissue factor response is decreased in patients with hyperlipidemia. Thromb Res 1999; 96: 283-292 10. Nakayama T, Sonoda S, Urano T, Yamada T, Okada M: Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases. Clin Chem 1993; 39: 293-297 29. Sandset PM, Larsen ML, Abildgaard U, Lindhal AK, Odegaard OR: Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): Levels in normal population and relation to cholesterol. Blood Coagul Fibrinolysis 1991; 2: 425-433 14. Fuster V, Fallon JT, Nemerson Y: Coronary thrombosis. Lancet 1996; 348: S7-S10 30. Lindahl AK, Jacobsen PB, Sandset PM, Abildgaard U: Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients. Blood Coagul Fibrinolysis 1991; 2: 713-721 13. Rappaport SI, Rao VM: Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 1992; 12: 1111-1121 21. Brett SE, Ritter JM, Chowienczyk PJ: Diastolic blood pressure changes during exercise positively correlate with serum cholesterol and insulin resistance. Circulation 2000; 101: 611-615 27. Zitoun D, Bara L, Basdevant A, Samama MM: Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias. Arterioscler Thromb Vasc Biol 1996; 1: 77-81 1. Meade TW: The epidemiology of atheroma, thrombosis and ischaemic heart disease. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, editors. Haemostasis and thrombosis. London: Churchill Livingstone, 1994: 1199-1227 20. Rowell LB: Human cardiovascular control. New York: Oxford University Press, 1993: 268-291 Zweifler AJ, Shahab ST (23) 1993; 11 Sandset PM, Larsen ML, Abildgaard U (29) 1991; 2 Meade TW (1) 1994 28 (4) 1990; 29 ABUMIYA T (7) 1995; 118 Rowell LB (20) 1993 Bellamy RF (18) 1982; 50 Lindahl AK, Sandset PM, Abildgaard (6) 1992; 3 Marmur JD, Thiruvikraman SV, Fyfe B (15) 1996; 94 (14) 1996; 348 Sandset PM, Lund H, Norseth J, Abil (25) 1991; 11 Nemerson Y (2) 1988; 71 Wilcox JN, Smith KM, Scwartz SM, Go (3) 1989; 86 Nakayama T, Sonoda S, Urano T, Yama (10) 1993; 39 Franklin SS, Khan SA, Wong ND, Lars (19) 1999; 100 Zitoun D, Bara L, Basdevant A, Sama (27) 1996; 1 Haskel EJ, Torr SR, Day KC, Palmier (12) 1991; 84 Brett SE, Ritter JM, Chowienczyk PJ (21) 2000; 101 Swan JW, Walton C, Godsland IF, Cro (31) 1994; 71 Smulyan H, Safar ME (22) 2000; 132 16 Rappaport SI, Rao VM (13) 1992; 12 Ikeda T, Shibuya Y, Senba U, Sugiuc (11) 1991; 5 Hansen JB, Huseby NE, Sandset PM, S (26) 1994; 14 Lindahl AK, Jacobsen PB, Sandset PM (30) 1991; 2 Kokawa T, Enjyoji K, Kumeda K, Kami (17) 1996; 16 Austen WG, Edwards JE, Frye RL, Gen (9) 1975; 51 Rappaport SI (5) 1991; 66 8 Kokawa T, Abumiya T, Kimura T, Hara (24) 1995; 15 |
| References_xml | – reference: 30. Lindahl AK, Jacobsen PB, Sandset PM, Abildgaard U: Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients. Blood Coagul Fibrinolysis 1991; 2: 713-721 – reference: 27. Zitoun D, Bara L, Basdevant A, Samama MM: Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias. Arterioscler Thromb Vasc Biol 1996; 1: 77-81 – reference: 25. Sandset PM, Lund H, Norseth J, Abildgaard U, Ose L: Treatment with hydroxymethylglutaryl: Coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system. Arterioscler Thromb 1991; 11: 138-145 – reference: 13. Rappaport SI, Rao VM: Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 1992; 12: 1111-1121 – reference: 15. Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, et al: Identification of active tissue factor in human coronary atheroma. Circulation 1996; 94: 1226-1232 – reference: 31. Swan JW, Walton C, Godsland IF, Crook D, Oliver MF, Stevenson JC: Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men. Br Heart J 1994; 71: 41-44 – reference: 5. Rappaport SI: The extrinsic pathway inhibitor: A regulator of TF-dependent blood coagulation. Thromb Haemost 1991; 66: 6-10 – reference: 8. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, et al: Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta 1993; 223: 53-71 – reference: 28. Rugeri L, Susen S, Bard JM, Corseaux D, Gaveriaux V, Devos P, et al: Monocyte tissue factor response is decreased in patients with hyperlipidemia. Thromb Res 1999; 96: 283-292 – reference: 10. Nakayama T, Sonoda S, Urano T, Yamada T, Okada M: Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases. Clin Chem 1993; 39: 293-297 – reference: 14. Fuster V, Fallon JT, Nemerson Y: Coronary thrombosis. Lancet 1996; 348: S7-S10 – reference: 11. Ikeda T, Shibuya Y, Senba U, Sugiuchi H, Araki S, Uji Y, et al: Automated immunoturbidimetric analysis of six plasma apolipoproteins: Correlation with radial immunodiffusion assays. J Clin Lab Anal 1991; 5: 90-95 – reference: 18. Bellamy RF: Diastolic coronary artery pressure: Flow relations in the dog. Circ Res 1982; 50: 334-341 – reference: 20. Rowell LB: Human cardiovascular control. New York: Oxford University Press, 1993: 268-291 – reference: 7. Abumiya T, Enjyoji K, Kokawa T, Kamikubo Y, Kato H: An anti tissue factor pathway inhibitor (TFPI) monoclonal antibody recognized the third Kunitz domain (K3) of free form of TFPI but not lipoprotein-associated forms in plasma. J Biochem 1995; 118: 178-182 – reference: 16. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, et al: Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 1989; 338: 518-520 – reference: 26. Hansen JB, Huseby NE, Sandset PM, Svensson B, Lyngmo V, Nordoy A: Tissue factor pathway inhibitor and lipoproteins: Evidence for association with and regulation by LDL in human plasma. Arterioscler Thromb 1994; 14: 223-229 – reference: 4. Broze GJ, Girard TJ, Novotny WF: Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990; 29: 7539-7546 – reference: 3. Wilcox JN, Smith KM, Scwartz SM, Gordon D: Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-2843 – reference: 9. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LSC, et al: A reporting system on patients evaluated for coronary artery disease: Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51: 5-40 – reference: 2. Nemerson Y: Tissue factor and haemostasis. Blood 1988; 71: 1-8 – reference: 12. Haskel EJ, Torr SR, Day KC, Palmier MO, Wun T-C, Sobel BE, et al: Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation 1991; 84: 821-827 – reference: 6. Lindahl AK, Sandset PM, Abildgaard U: The present status of tissue factor pathway inhibitor. Blood Coagul Fibrinolysis 1992; 3: 439-449 – reference: 17. Kokawa T, Enjyoji K, Kumeda K, Kamikubo Y, Harada-Shiba M, Koh H, et al: Measurement of the free form of TFPI antigen in hyperlipidemia: Relationship between free and endothelial cell-associated forms of TFPI. Arterioscler Thromb Vasc Biol 1996; 16: 802-808 – reference: 1. Meade TW: The epidemiology of atheroma, thrombosis and ischaemic heart disease. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, editors. Haemostasis and thrombosis. London: Churchill Livingstone, 1994: 1199-1227 – reference: 23. Zweifler AJ, Shahab ST: Pseudohypertension: A new assessment. J Hypertens 1993; 11: 1-6 – reference: 29. Sandset PM, Larsen ML, Abildgaard U, Lindhal AK, Odegaard OR: Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): Levels in normal population and relation to cholesterol. Blood Coagul Fibrinolysis 1991; 2: 425-433 – reference: 22. Smulyan H, Safar ME: The diastolic blood pressure in systolic hypertension. Ann Intern Med 2000; 132: 233-237 – reference: 21. Brett SE, Ritter JM, Chowienczyk PJ: Diastolic blood pressure changes during exercise positively correlate with serum cholesterol and insulin resistance. Circulation 2000; 101: 611-615 – reference: 24. Kokawa T, Abumiya T, Kimura T, Harada-Shiba M, Koh H, Tsushima M, et al: Tissue factor pathway inhibitor activity in human plasma: Measurement of lipoprotein-associated and free forms in hyperlipidemia. Arterioscler Thromb Vasc Biol 1995; 15: 504-510 – reference: 19. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D: Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999; 100: 354-360 – volume: 51 start-page: 5 issn: 0009-7322 year: 1975 ident: 9 publication-title: Circulation doi: 10.1161/01.CIR.51.4.5 – volume: 39 start-page: 293 year: 1993 ident: 10 publication-title: Clin Chem doi: 10.1093/clinchem/39.2.293 – ident: 8 doi: 10.1016/0009-8981(93)90062-9 – volume: 71 start-page: 41 issn: 0007-0769 year: 1994 ident: 31 publication-title: Br Heart J doi: 10.1136/hrt.71.1.41 – volume: 132 start-page: 233 issn: 0003-4819 year: 2000 ident: 22 publication-title: Ann Intern Med doi: 10.7326/0003-4819-132-3-200002010-00010 – volume: 84 start-page: 821 issn: 0009-7322 year: 1991 ident: 12 publication-title: Circulation doi: 10.1161/01.CIR.84.2.821 – volume: 12 start-page: 1111 issn: 1049-8834 year: 1992 ident: 13 publication-title: Arterioscler Thromb doi: 10.1161/01.ATV.12.10.1111 – volume: 94 start-page: 1226 issn: 0009-7322 year: 1996 ident: 15 publication-title: Circulation doi: 10.1161/01.CIR.94.6.1226 – volume: 29 start-page: 7539 issn: 0006-2960 issue: 33 year: 1990 ident: 4 publication-title: Biochemistry doi: 10.1021/bi00485a001 – volume: 15 start-page: 504 issn: 1079-5642 year: 1995 ident: 24 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.15.4.504 – volume: 66 start-page: 6 issn: 0340-6245 year: 1991 ident: 5 publication-title: Thromb Haemost doi: 10.1055/s-0038-1646367 – start-page: 268 year: 1993 ident: 20 – volume: 1 start-page: 77 issn: 1079-5642 year: 1996 ident: 27 publication-title: Arterioscler Thromb Vasc Biol – start-page: 1199 year: 1994 ident: 1 – volume: 101 start-page: 611 issn: 0009-7322 year: 2000 ident: 21 publication-title: Circulation doi: 10.1161/01.CIR.101.6.611 – volume: 2 start-page: 425 issn: 0957-5235 year: 1991 ident: 29 publication-title: Blood Coagul Fibrinolysis doi: 10.1097/00001721-199106000-00004 – volume: 118 start-page: 178 issn: 0021-924X issue: 1 year: 1995 ident: 7 publication-title: J Biochem doi: 10.1093/oxfordjournals.jbchem.a124874 – volume: 5 start-page: 90 issn: 0887-8013 year: 1991 ident: 11 publication-title: J Clin Lab Anal doi: 10.1002/jcla.1860050204 – volume: 100 start-page: 354 issn: 0009-7322 year: 1999 ident: 19 publication-title: Circulation doi: 10.1161/01.CIR.100.4.354 – volume: 3 start-page: 439 issn: 0957-5235 year: 1992 ident: 6 publication-title: Blood Coagul Fibrinolysis doi: 10.1097/00001721-199203040-00011 – ident: 16 doi: 10.1038/338518a0 – volume: 14 start-page: 223 issn: 1049-8834 year: 1994 ident: 26 publication-title: Arterioscler Thromb doi: 10.1161/01.ATV.14.2.223 – volume: 11 start-page: 138 issn: 1049-8834 year: 1991 ident: 25 publication-title: Arterioscler Thromb doi: 10.1161/01.ATV.11.1.138 – volume: 11 start-page: 1 issn: 0263-6352 year: 1993 ident: 23 publication-title: J Hypertens doi: 10.1097/00004872-199301000-00001 – volume: 86 start-page: 2839 issn: 0027-8424 year: 1989 ident: 3 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.86.8.2839 – volume: 348 start-page: S7 issn: 0140-6736 issue: Suppl 1 year: 1996 ident: 14 publication-title: Lancet – volume: 71 start-page: 1 issn: 0006-4971 year: 1988 ident: 2 publication-title: Blood doi: 10.1182/blood.V71.1.1.1 – volume: 50 start-page: 334 issn: 0009-7330 year: 1982 ident: 18 publication-title: Circ Res doi: 10.1161/01.RES.50.5.747 – ident: 28 doi: 10.1016/S0049-3848(99)00112-7 – volume: 16 start-page: 802 issn: 1079-5642 year: 1996 ident: 17 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.16.6.802 – volume: 2 start-page: 713 issn: 0957-5235 year: 1991 ident: 30 publication-title: Blood Coagul Fibrinolysis doi: 10.1097/00001721-199112000-00004 |
| SSID | ssj0027455 |
| Score | 1.2937146 |
| Snippet | There are only a few studies of the relationship between hemostatic abnormalities and intraarterial pressure, so the present study investigated the association... |
| SourceID | unpaywall proquest pubmed pascalfrancis crossref jstage |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 165 |
| SubjectTerms | Adult Aged Anticoagulants - blood Biological and medical sciences Blood Pressure Cardiology. Vascular system Coronary Angiography Coronary Disease - blood Coronary heart disease Diastolic blood pressure Female Heart Hemostatics - blood Humans Lipids - blood Lipoproteins - blood Male Medical sciences Middle Aged Regression Analysis TFPI Tissue factor |
| Title | Level of Plasma Tissue Factor Pathway Inhibitor is Inversely Correlated With Intraarterial Diastolic Pressure in Subjects Who Underwent Coronary Angiography |
| URI | https://www.jstage.jst.go.jp/article/jcj/65/3/65_3_165/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/11266189 https://www.proquest.com/docview/76996072 https://www.jstage.jst.go.jp/article/jcj/65/3/65_3_165/_pdf |
| UnpaywallVersion | publishedVersion |
| Volume | 65 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | JAPANESE CIRCULATION JOURNAL, 2001, Vol.65(3), pp.165-170 |
| journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1347-4839 dateEnd: 20011231 omitProxy: true ssIdentifier: ssj0027455 issn: 0047-1828 databaseCode: DIK dateStart: 19600101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NDvHxwPdHYAxL7IWHpEtsJ6l4qgbVBmzqw6YNaVJkO3abEpKqTVWVv4U_lnOTlIEmhJCq1qpPTnJ3tn8X3wfAHueBoDpkLtdSufZgzpU9n7tKIjynvgppZAOFj0_CwzP28YJfbMG7NhbGulVOEBeNtP3xRqU3mXYbJnYnatINeZfiV0ITH5vJNDU3YDvkCMQ7sH12Mux_qc-UIxeR8zoQjmKbIQ5okpMGnNqBvJB7vt1SrmxHN-srW_9IMUcWmbq2xXXg8y7cXhRTsVqKPL-yIQ3uw2X7KLUfyldvUUlPff8jy-N_PusDuNcAVdKvCR_Cli4ewa3j5ij-Mfz4bN2NSGnIEAH4N0FO1yIkg3UBHzJEZLkUK3JUjDOZ2X-yObFJPWZzna_IgS0KkiPOTcl5Vo2xp5qJtXspzgfyPhOISfNMkTp6caZJVhBc4-xLozk5H5dkXa9piTumHaq0McWkX4yyJgH3EzgbfDg9OHSbUg-uYj1auVSg6YKWn0x7-1zHEo3GmPlprFRPmliExsgo9kNlM7AZZgynUsTS97XeF0GcSvoUOkVZ6OdAsIMyJplQMWNKRsIP0lAIEwXSUC6ZA29biSeqyYNuy3HkibWHUDsSZH2CXEeeO_BmQzuts39cSxXXYtzQNEJsaWjSCnHTY2PqcGFyYOc3VduMgGYxrpYOvG41L8Fpb89yRKHLxTyJQptWJwoceFYr5K_78y3minsO7G009C83_-LfyF7Cndr7zn52oFPNFvoVwrFK7qIhcvRpt5l8PwGpcTnA |
| linkProvider | Unpaywall |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NDvHxwPcgMMASe-Eh6RLbSSqeqkE1EJv6sGpDQopsx25TsqRqU1Xlb-GP5dwkZaAJIaSqteqTk9yd7d_F9wFwwHkgqA6Zy7VUrj2Yc2XP566SCM-pr0Ia2UDhk9PweMQ-XfCLHXjXxsJYt8op4qKxtj_euPSms27DxO5UTbsh71L8SmjiYzOZpeYG7IYcgXgHdkenw_6X-kw5chE5bwLhKLYZ4oAmOWnAqR3IC7nn2y3lynZ0s76y9Y8UC2SRqWtbXAc-78LtZTET65XI8ysb0uA-fG0fpfZD-eYtK-mp739kefzPZ30A9xqgSvo14UPY0cUjuHXSHMU_hh-frbsRKQ0ZIgC_FORsI0Iy2BTwIUNEliuxJh-LSSYz-0-2IDapx3yh8zU5skVBcsS5KTnPqgn2VHOxcS_F-UDeZwIxaZ4pUkcvzjXJCoJrnH1ptCDnk5Js6jWtcMe0Q5U2ppj0i3HWJOB-AqPBh7OjY7cp9eAq1qOVSwWaLmj5ybR3yHUs0WiMmZ_GSvWkiUVojIxiP1Q2A5thxnAqRSx9X-tDEcSppHvQKcpCPwOCHZQxyYSKGVMyEn6QhkKYKJCGcskceNtKPFFNHnRbjiNPrD2E2pEg6xPkOvLcgTdb2lmd_eNaqrgW45amEWJLQ5NWiNseG1OHC5MD-7-p2nYENItxtXTgdat5CU57e5YjCl0uF0kU2rQ6UeDA01ohf92fbzFX3HPgYKuhf7n55_9G9gLu1N539rMPnWq-1C8RjlXyVTPtfgJUpzjH |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Level+of+Plasma+Tissue+Factor+Pathway+Inhibitor+is+Inversely+Correlated+With+Intraarterial+Diastolic+Pressure+in+Subjects+Who+Underwent+Coronary+Angiography&rft.jtitle=Japanese+circulation+journal&rft.au=Masuoka%2C+Hiroshi&rft.au=Ito%2C+Masaaki&rft.au=Kamei%2C+Shigeru&rft.au=Ozaki%2C+Morihiro&rft.date=2001&rft.issn=0047-1828&rft.eissn=1347-4839&rft.volume=65&rft.issue=3&rft.spage=165&rft.epage=170&rft_id=info:doi/10.1253%2Fjcj.65.165&rft.externalDBID=n%2Fa&rft.externalDocID=10_1253_jcj_65_165 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0047-1828&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0047-1828&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0047-1828&client=summon |